DVA vs JAGX · P/E 14, rev $6.97B vs rev $1.2M
DaVita HealthCare Partners Inc (DVA) versus Jaguar Animal Health Inc (JAGX) — a side-by-side from cached financials, not a winner call.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Jaguar Animal Health Inc (JAGX) is a biotechnology company listed on NASDAQ.
Latest reported DVA revenue for 2026-06-30 was $6.97B. Net income was $462.9M. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Latest reported JAGX revenue for 2026-06-30 was $1.2M. Net income was -$12.8M. Revenue was down 94.0% from 2026-03-31 to 2026-06-30. JAGX currently screens at market cap $1.7M.
DVA currently screens at market cap $10.77B and trailing P/E 14.1. JAGX currently screens at market cap $1.7M.
Not investment advice. Open the DVA and JAGX stock pages for the full models.
Not investment advice.